METHOD FOR SELECTING SUBJECT-DERIVED NEOANTIGEN

Validation of Neoepitope Presentation

COMPOSITIONS AND METHODS FOR SCREENING AND IDENTIFYING IMMUNE MODULATORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF

MICROFLUIDIC TRANSWELL SYSTEMS FOR IMAGING PAIRED CELL INTERACTIONS VIA EXOSOMES

COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES

METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS

MATERIALS AND METHODS FOR EVALUATION OF ANTIGEN PRESENTATION MACHINERY COMPONENTS AND USES THEREOF

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Panel comprising Borrelia MHC multimers

IL-10-Producing CD4+ T Cells and Uses Thereof

COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES

METHODS AND COMPOSITIONS FOR TREATING GLIOMAS

T Cell Receptor Identification

T CELL RECEPTOR MULTIMERS AND USES THEREOF

IMMUNOASSAY FOR DETECTING BIOLOGICALLY ACTIVE PROTEINS

METHOD FOR CLASSIFYING CELLS

SYSTEMS AND METHODS FOR GENERATING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) MOLECULES WITH DESIRED PEPTIDE-BINDING SPECIFICITIES

METHODS OF TREATING IMMUNOTHERAPY-ASSOCIATED ADVERSE EFFECTS

ANTIBODIES

METHODS AND SYSTEMS FOR DEVELOPING PERSONALIZED VACCINE BY IDENTIFICATION AND PRIORITIZATION OF MUTATION-DERIVED NEOANTIGENS

BISPECIFIC BINDING AGENT

PRAME IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING PRAME IMMUNOGENIC PEPTIDES, AND USES THEREOF

Coronavirus T Cell Epitopes, Megapools and Uses Thereof

BIOMARKERS FOR SEVERITY OF ISCHEMIC STROKE AND USE THEREOF

METHOD OF DETECTING HUMAN LEUKOCYTE ANTIGENS (HLA)

SYSTEMS AND METHODS FOR DETECTING ANALYTES FROM CAPTURED SINGLE BIOLOGICAL PARTICLES

METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS

NEW USE OF PEG-PHOSPHOLIPID MOLECULES

AFUCOSYLATION OF HLA-SPECIFIC IGG1 AS A POTENTIAL PREDICTOR OF ANTIBODY PATHOGENICITY IN KIDNEY TRANSPLANTATION

USE OF CD38+HLA-DR+CD8+ T CELL IN EARLY DIAGNOSIS OF ACUTE GRAFT-VERSUS-HOST DISEASE

TUMOR MHC CLASS I EXPRESSION IS ASSOCIATED WITH INTERLEUKIN-2 RESPONSE IN MELANOMA

UTERINE CANCER TREATMENTS

COMPOSITIONS AND METHODS FOR CHARACTERIZING T CELL, OR T CELL-LIKE, RECEPTORS FROM SINGLE CELLS

METHODS OF ANALYZING A SAMPLE FOR CANCER-SPECIFIC IMMUNE CELLS

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS

Method for predicting response to cancer immunotherapy

METHOD FOR HIGH THROUGHPUT PEPTIDE-MHC AFFINITY SCREENING FOR TCR LIGANDS

METHODS FOR DESIGNING IMMUNOTHERAPIES AND TREATMENTS USING SAME

METHODS AND SYSTEMS FOR ASSESSING IMMUNE CELL RECEPTORS AND ANTIGENS

COMPOSITIONS AND METHODS FOR DIAGNOSING AUTOIMMUNE AQUAPORINOPATHY

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

CELLULAR ASSAYS AND METHODS TO ASSESS MHC-PEPTIDE-TCR INTERACTIONS AND KINETICS

OFF-TARGET PREDICTION METHOD FOR ANTIGEN-RECOGNITION MOLECULES BINDING TO MHC-PEPTIDE TARGETS

IDENTIFICATION AND USES OF PEPTIDE SEQUENCES OF SARS-COV-2 T CELL AND B CELL EPITOPES

IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY

Proto-Antigen-Presenting Synthetic Surfaces, Activated T Cells, and Uses Thereof

METHOD FOR PREDICTING THE OFF-TARGET BINDING OF A PEPTIDE WHICH BINDS TO A TARGET PEPTIDE PRESENTED BY A MAJOR HISTOCOMPATIBILITY COMPLEX

METHODS FOR DETECTING PEPTIDE/MHC/TCR BINDING

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

SELECTION OF PATIENTS FOR COMBINATION THERAPY

PEPTIDE EXCHANGE SYSTEM AND METHOD

METHOD FOR THE ABSOLUTE QUANTIFICATION OF NATURALLY PROCESSED HLA-RESTRICTED CANCER PEPTIDES

Methods for Identification of Exchangeable MHC Binding Peptides and Methods of Use Thereof

ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCII PEPTIDE BINDING

NEUROPROTECTIVE COMPOSITIONS AND METHODS

FUCOSYLATION AND IMMUNE SURVEILLANCE IN MELANOMA

ANTIBODY AND USE THEREOF

HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES

SYSTEM AND METHOD FOR DISCOVERING VALIDATING AND PERSONALIZING TRANSPOSABLE ELEMENT CANCER VACCINES

BIOELECTRONIC SYSTEM FOR RARE CELL SEPARATION AND APPLICATION THEREOF

METHODS OF ASSESSING CELL PRODUCTS

LIGAND DISCOVERY FOR T CELL RECEPTORS

COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR IDENTIFICATION

MICROBIOTA SEQUENCE VARIANTS OF TUMOR-RELATED ANTIGENIC EPITOPES

ADMINISTRATION OF ANTI-TUMOR VACCINES

METHODS AND COMPOSITIONS COMPRISING MHC CLASS PEPTIDES

HLA HAPLOTYPES AS BIOMARKERS FOR COVID-19 SYMPTOM SEVERITY

Systems and methods for identifying HLA-associated tumor peptides

ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS

ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCI PEPTIDE BINDING

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

BETA2-MICROGLOBULIN CONCENTRATION ANALYZING METHOD AND DEVICE

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

Reusable Cartridges for Detecting Analytes in Solution

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

BIOINFORMATICS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Method for treating non-small lung cancer with a population of activated T cells

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

METHODS FOR STRATIFYING DIABETES PATIENTS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

STABILIZATION OF MHC COMPLEXES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

USES OF BIOMARKERS FOR IMPROVING IMMUNOTHERAPY

CTL PEPTIDE EPITOPES AND ANTIGEN-SPECIFIC T CELLS, METHODS FOR THEIR DISCOVERY, AND USES THEREOF

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

Peptides and T cells for use in immunotherapeutic treatment of various cancers

COMPOSITIONS AND METHODS FOR IDENTIFYING MHC-II BINDING PEPTIDES

Peptides and T cells for use in immunotherapeutic treatment of various cancers

Peptides and T cells for use in immunotherapeutic treatment of various cancers

METHODS OF IDENTIFYING T CELL RECEPTORS

METHOD FOR THE ABSOLUTE QUANTIFICATION OF MHC MOLECULES

HIGH YIELD PRODUCTION AND USE OF ENZYMATIC-EXCHANGEABLE PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SINGLE CHAIN TRIMER TETRAMER

Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma

Peptides and T cells for use in immunotherapeutic treatment of various cancers

GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

Ligand discovery for T cell receptors

Method for treating non-small lung cancer with a population of activated cells

Peptides and T cells for use in immunotherapeutic treatment of various cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

SELECTION OF FIBROBLAST DONORS FOR OPTIMIZATION OF ALLOGENEIC FIBROBLAST-MEDIATED REGENERATION

Peptides and T cells for use in immunotherapeutic treatment of various cancers

Peptides and T cells for use in immunotherapeutic treatment of various cancers

SELECTION OF T CELL RECEPTORS

Methods for detecting peptide/MHC/TCR binding

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Detection of human leukocyte antigen-A*32:01 in connection with determining drug reaction with eosinophilia and systemic symptoms (DRESS) and methods of treating bacterial infection in a subject with vancomycin-induced DRESS

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

METHODS OF MAKING AND USING SOLUBLE MHC MOLECULES

PREDICTING T CELL EPITOPES USEFUL FOR VACCINATION

AFFINITY-OLIGONUCLEOTIDE CONJUGATES AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Panel comprising MHC multimers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides, combination of peptides as targets and for use in immunotherapy

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Method and system for neoantigen analysis

HLA SINGLE ALLELE LINES

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Uterine cancer treatments

Uterine cancer treatments

DIAGNOSIS OF ENDOMETRIOSIS BY DECREASED PROTEIN LEVELS OF BETA2-MICROGLOBULIN PROTEIN (BETA2M) AND ONE OR MORE FURTHER BIOMARKERS

Atypical hemolytic uremic syndrome (AHUS) biomarker proteins

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

REAGENTS AND METHODS FOR IDENTIFYING, ENRICHING, AND/OR EXPANDING ANTIGEN-SPECIFIC T CELLS

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex

Selection of patients for combination therapy

METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS

PROTEIN BIOMARKERS FOR NEPHROPATHY AND APPLICATIONS THEREOF

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Biomarkers for Ovarian Cancer: B2 Microglobulin

MHC-II GENOTYPE RESTRICTS THE ONCOGENIC MUTATIONAL LANDSCAPE

Peptides and combination of peptides for use in immunotherapy against various tumors

METHODS FOR IDENTIFYING RNA EDITING-DERIVED EPITOPES THAT ELICIT IMMUNE RESPONSES IN CANCER

ANTIGEN BINDING PROTEINS WHICH BIND TO THE pMHC HLA-DQ2.5:DQ2.5 PRESENTING A GLIADIN PEPTIDE

ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

MAMMALIAN MHC PEPTIDE DISPLAY AS AN EPITOPE SELECTION TOOL FOR VACCINE DESIGN

PEPTIDES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

PEPTIDES OF PAGE5

PEPTIDES

METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES

Ligand discovery for T cell receptors

Ligand discovery for T cell receptors

Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers

Enhancing T cell activation using altered MHC-peptide ligands

Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens

MHC Peptide Complexes and Uses Thereof in Infectious Diseases

Fucosylation and immune surveillance in melanoma

Peptide exchange system and method

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

Method of treating with a peptide

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

DIAGNOSIS OF CROHN'S DlSEASE AND ULCERATIVE COLITIS

Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Method of treating with a peptide

Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment

Lymphocyte biomarkers for determining the clinical response to cell therapy

Validation of Neoepitope Presentation

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Agents and methods to elicit anti-tumor immune response

METHODS FOR ASSESSING GRAFT FAILURE RISK

Compositions and methods for inhibition of MICA/B shedding

NEOANTIGEN ANALYSIS

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION

DETECTION OF LEUKOCYTE-DERIVED MICROVESICLES BY FLUO-SENSITIVE FLOW CYTOMETRY

Method for the absolute quantification of naturally processed hla-restricted cancer peptides

Method for the detection, preparation and depletion of CD4+ t lymphocytes

Anti-HLA-G antibodies and use thereof

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Method for high throughput peptide-MHC affinity screening for TCR ligands

Affinity-oligonucleotide conjugates and uses thereof

Relaxin1 derived peptides for use in immunotherapy

Uterine cancer treatments

COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Method of treating with a peptide

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Microbiota sequence variants of tumor-related antigenic epitopes

Peptides and combination of peptides for use in immunotherapy against various tumors

Compositions and Methods of Identifying Tumor Specific Neoantigens

METHODS AND KITS FOR DETECTING BASOPHIL ACTIVATION

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS

Methods for detecting peptide/MHC/TCR binding

CONSTRUCTS TARGETING NY-ESO-1 PEPTIDE/MHC COMPLEXES AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells

NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF

IDENTIFICATION AND GENERATION OF PERSONALIZED VACCINE COMPONENTS BY FUNCTIONAL SCREENING VARIABLE EPITOPE AND MIMOTOPE LIBRARIES

Method for producing an examination reagent and kit for analysing a T-cell frequency

MHC-E RESTRICTED EPITOPES, BINDING MOLECULES AND RELATED METHODS AND USES

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions

Systems and methods for identifying HLA-associated tumor peptides

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition

SOLUBLE TCR MOLECULES AND METHODS OF USE

Predicting T cell epitopes useful for vaccination

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS

DETECTION AND TREATMENT OF CANCER

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT)

ANTI-HLA MONOCLONAL CHIMERIC IMMUNOGLOBULIN, PROCESS AND KIT EMPLOYING SUCH A MONOCLONAL CHIMERIC IMMUNOGLOBULIN

COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MOLECULES DERIVED FROM MICROBIOTA FOR TREATMENT OF DISEASE

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Methods and compositions for the diagnosis and treatment of cancer

Method of monitoring the efficacy of the anti-clever-1 therapy in cancer

Immunotherapy against melanoma and other cancers

COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS

Uterine cancer treatments

Uterine cancer treatments

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

MHC class I associated hepatitis B peptides

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

METHODS FOR DETERMINING TUMOUR PHENOTYPES

Single cell characterization using affinity-oligonucleotide conjugates and vessel barcoded polynucleotides

Uterine cancer treatments

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

PEPTIDES OF PAGE5

PEPTIDES

MHC-bound peptide arrays and methods of use thereof